Duration of protective immunity following COVID‐19 vaccination of individuals with underlying health conditions: A rapid reviewCOVID-19effectivenessimmunocompromisedSARS-CoV-2underlying conditionsvaccineVACCINESThe World Health Organization has stated that the primary goal of immunisation in the COVID-19 ...
"Ultimately, we don't know what the strength or duration of natural immunity to SARS-CoV-2 - or a potential vaccine - will look like," explained co-first author Caroline Wagner, an Assistant Professor of Bioengineering at McGill University who worked on the study as a...
as well as one small animal model study, suggest that recovery from COVID-19 might confer immunity against reinfection, at least temporarily. However, the immune response to COVID-19 is not yet fully understood and definitive data on postinfection immunity are lacking. Amidst the uncertainty...
33 So, as we consider future waves, two critical questions remain about the duration of protection: how significantly will immunity wane? And will booster uptake continue to slow in each subsequent round of boosting?The next wave of medical advances will also prompt questions. Pfizer and Moderna...
Aging in COVID-19: vulnerability, immunity and intervention. Ageing Res Rev. 2021;65:101205-101205. doi:10.1016/j.arr.2020.101205PubMedGoogle Scholar 166. Virlogeux V, Fang VJ, Wu JT, et al. Brief report: incubation period duration and severity of clinical disease following ...
vulnerable individuals need to be shielded until herd immunity has developed in their area. We explore the characteristics and duration of this strategy using a novel individual-based model for geographically stratified transmission of COVID-19 in a country. The model predicts that individuals will ha...
Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and associated mortality than the general population. Owing to this increased risk, patients with cancer have been prioritized for COVID-19 vaccination globally, for both primary and booster vaccinations. However, given...
We examine stock price reactions to the COVID-19 pandemic using an international setting and conditioning on a constellation of corporate characteristics that also could shape stock price reactions to the pandemic to identify the influence of CSR activities on corporate immunity to COVID-19. Fourth,...
Data on effectiveness and protection duration of Covid-19 vaccines and previous infection against general SARS-CoV-2 infection in general populations are limited. Here we evaluate protection from Covid-19 vaccination (primary series) and previous infecti
Can you become immune to COVID-19? Patients who recover from COVID-19 make antibodies to the virus that may impart immunity for at least 6 months; however, breakthrough infections do occur and may be more likely with newly circulating variants of the virus. Immunizing with the latest ...